Attendees Invited to Experience Integer’s New Booth #3201PLANO, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, will exhibit during MD&M West 2026 in Anaheim, Calif., Feb. 3 – 5. Integer will unveil a significantly expanded 20 x 50 sq. ft. new booth #3201, showcasing the company’s full range of customer solutions. On prominent display will be R&D Velocity, Integer’s ...

An inherent conflict has now arisen between time to market and the design of a company’s device not being done. This is a real problem because when you have to urgently produce sellable product, after validation and beyond assumptions that the product's actually reliable, the product’s entire developmental life cycle has been disrupted. This is because this developmental life cycle now overlaps with factors such as R&D, prototyping, and optimisation.While this is great for business, Covid effectively caused ...

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation (ITGR) for allegedly misleading investors regarding its competitive position and sales performance in the EP manufacturing market [2][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities who purchased Integer common stock between July 25, 2024, and October 22, 2025, inclusive [2]. - Investors have until February 9, 2026, to apply to the Court to be appointed as lead plaintiff in the lawsuit [2]. Group 2: Allegations - The Complaint alleges that the Company materially overstated its competitive position within the EP manufacturing market [3]. - It claims that despite the Company's assertions of strong visibility into customer demand, there was a sustained deterioration in sales related to two of its EP devices [3]. - The Company mischaracterized its EP devices as a long-term growth driver for its C&V segment, leading to materially false and misleading statements about its business and prospects [3]. Group 3: Next Steps for Investors - Investors who purchased Integer shares and suffered losses are encouraged to contact the law firm for more information or to discuss their rights [4].

Acquisition Details - Perimeter Solutions, Inc. has completed the acquisition of Medical Manufacturing Technologies LLC for approximately $685 million in cash, including certain tax benefits [1] - The acquisition was financed using cash on hand and proceeds from a senior secured notes offering that closed on January 2, 2026 [1] Company Overview - Perimeter Solutions is a leading global solutions provider for the Fire Safety and Specialty Products industries, organized into two reporting segments: Fire Safety and Specialty Products [4] Fire Safety Segment - The Fire Safety segment formulates and manufactures fire management products to combat various types of fires, including wildland and structural fires [5] - This segment also offers specialized equipment and services to support firefighting operations, including mobile retardant bases and custom-designed equipment [5] - The service network can meet emergency resupply needs for approximately 150 air tanker bases in North America and other global locations [5] Specialty Products Segment - The Specialty Products segment develops and markets products for non-fire safety markets, including phosphorus derivatives and electronic components [6] - Phosphorus Pentasulfide produced by this segment is used in lubricant additives, pesticides, mining chemicals, and emerging electric battery technologies [6] - Intelligent Manufacturing Solutions within this segment focuses on a variety of product lines across communications, energy, defense, and industrial systems, with an emphasis on aftermarket repair and replacement [6] Medical Manufacturing Technologies (MMT) - MMT is a leading provider of highly engineered machinery and aftermarket consumables for minimally invasive medical devices, with nearly all revenue from proprietary products and about half from the aftermarket [2]

Core Viewpoint - Integer Holdings Corporation has faced significant challenges, leading to a class action lawsuit due to misleading statements regarding its business performance and sales projections [4]. Financial Performance - On October 23, 2025, Integer reduced its full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion, which was below prior expectations [2]. - The company anticipated net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026 [2]. - Sales of three new products, including two electrophysiology devices, were expected to decline in 2026, with slower market adoption than forecasted [2]. Stock Market Reaction - Following the announcement of reduced sales guidance, Integer's stock price fell by $35.22 per share, or 32.3%, closing at $73.89 per share on October 23, 2025 [3]. Lawsuit Details - The class action lawsuit alleges that Integer made materially false and misleading statements and failed to disclose adverse facts about its business and operations [4]. - Specific allegations include overstating its competitive position in the electrophysiology manufacturing market and mischaracterizing its EP devices as long-term growth drivers [4]. Legal Action - Investors who purchased Integer common stock during the class period (July 25, 2024, to October 22, 2025) have until February 9, 2026, to file a lead plaintiff motion in the class action [1][5].

Core Viewpoint - Integer Holdings Corporation will host a conference call to discuss its financial results and business highlights for Q4 and the full year of 2025 on February 19, 2026 [1] Group 1: Conference Call Details - The conference call is scheduled for February 19, 2026, at 8 a.m. CT / 9 a.m. ET [1] - An audio replay of the conference call will be available for seven days, accessible by dialing (800) 770-2030 or (609) 800-9909 with Conference ID 3120125 [2] - The call will also be available live and via archived replay on the Investor Relations section of the Integer website [2] Group 2: Company Overview - Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations (CDMO) globally, serving markets such as cardiac rhythm management and neuromodulation [4] - The company aims to enhance patient lives by providing innovative, high-quality products and solutions [4] - Integer's brands include Greatbatch Medical and Lake Region Medical [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Integer Holdings Corporation during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Integer common stock between July 25, 2024, and October 22, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 9, 2026 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Integer Holdings Corporation made materially false and misleading statements regarding its competitive position in the electrophysiology manufacturing market and mischaracterized its EP devices as growth drivers [5]. - It is claimed that Integer experienced a deterioration in sales for two of its EP devices, contradicting its claims of strong customer demand [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Integer Holdings Corporation during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Integer common stock between July 25, 2024, and October 22, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 9, 2026 [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action litigation [4]. Group 3: Case Allegations - The lawsuit alleges that Integer Holdings Corporation made materially false and misleading statements regarding its competitive position in the electrophysiology manufacturing market and the performance of its EP devices [5]. - It is claimed that Integer misrepresented its EP devices as a long-term growth driver for its cardio and vascular segment, leading to investor damages when the true situation was revealed [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Integer Holdings Corporation during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Integer common stock between July 25, 2024, and October 22, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 9, 2026 [3] - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4] Group 3: Case Allegations - The lawsuit alleges that Integer Holdings Corporation made materially false and misleading statements regarding its competitive position in the electrophysiology manufacturing market and the performance of its EP devices [5] - It is claimed that Integer misrepresented its sales and growth prospects, leading to investor damages when the true situation was revealed [5]

Core Insights - Integer Holdings Corporation is participating in the North American Neuromodulation Society Annual Meeting in Las Vegas from January 22 to 25, 2026, showcasing its advancements in neuromodulation and miniaturized active implantable medical devices [1][2]. Group 1: Company Overview - Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations (CDMO) globally, serving markets such as cardiac rhythm management and neuromodulation [5]. - The company is recognized as a strategic partner for medical device companies and OEMs, focusing on enhancing patient lives through innovative and high-quality products [5]. Group 2: Product Innovations - At booth 115, Integer will highlight its latest innovations aimed at accelerating development timelines and reducing risks for medical device companies [2]. - The company is showcasing its Xcellion Gen 3 Fast Charge Lithium Ion battery technology, which provides best-in-class runtime and can recharge in as little as 30 minutes [3]. Group 3: Industry Trends - The trend of miniaturization is significantly impacting the future of implantable technologies, with Integer positioning itself as a key player in this transformation [3].